Published in Circulation on June 01, 1994
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest (2004) 1.77
Atrial tachycardia provoked in the presence of activating autoantibodies to β2-adrenergic receptor in the rabbit. Heart Rhythm (2012) 1.49
Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension (2012) 1.29
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med (1995) 1.23
Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circ Res (2013) 1.13
Receptor-activating autoantibodies and disease: preeclampsia and beyond. Expert Rev Clin Immunol (2011) 0.98
Autoimmune hypertensive syndrome. Hypertension (2007) 0.94
Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes. Mol Cell Biochem (1997) 0.90
Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization. Cardiovasc Res (2012) 0.88
Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol (2009) 0.88
Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function. Br J Pharmacol (2012) 0.87
IgG subclass reactivity to human cardiac myosin in cardiomyopathy patients is indicative of a Th1-like autoimmune disease. Clin Exp Immunol (1999) 0.87
Antibodies against the cardiac sodium/bicarbonate co-transporter (NBCe1) as pharmacological tools. Br J Pharmacol (2011) 0.86
Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor. Clin Exp Immunol (2006) 0.85
Peptide design by artificial neural networks and computer-based evolutionary search. Proc Natl Acad Sci U S A (1998) 0.85
The control of adrenergic function in heart failure: therapeutic intervention. Heart Fail Rev (2000) 0.83
Modulation of cardiocyte functional activity by antibodies against trypanosoma cruzi ribosomal P2 protein C terminus. Infect Immun (2000) 0.83
Role of autoantibodies in the physiopathology of Chagas' disease. Arq Bras Cardiol (2008) 0.83
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine. Heart Fail Rev (2012) 0.82
Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors. J Am Soc Hypertens (2009) 0.82
Novel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat model. PLoS One (2015) 0.81
β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways. PLoS One (2012) 0.81
Decreased autophagy in rat heart induced by anti-β1-adrenergic receptor autoantibodies contributes to the decline in mitochondrial membrane potential. PLoS One (2013) 0.81
Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure. Curr Cardiol Rev (2008) 0.81
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev (2013) 0.80
Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. J Biol Chem (2013) 0.80
Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev (2013) 0.80
Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy. Stem Cells Int (2013) 0.80
Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography. PLoS One (2012) 0.79
Antibodies in the pathogenesis of hypertension. Biomed Res Int (2014) 0.78
Cholinergic activity as a new target in diseases of the heart. Mol Med (2015) 0.78
Etanercept induces low QRS voltage and autonomic dysfunction in mice with experimental Chagas disease. Arq Bras Cardiol (2013) 0.77
Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy. J Clin Pathol (1999) 0.77
Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents. World J Gastroenterol (2004) 0.77
Decreased autophagy: a major factor for cardiomyocyte death induced by β1-adrenoceptor autoantibodies. Cell Death Dis (2015) 0.77
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs. J Physiol (2016) 0.76
Autoantibodies and cardiovascular dysfunction: cause or consequence? Curr Heart Fail Rep (2014) 0.76
Increases in circulating T lymphocytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyopathy. Heart Vessels (2007) 0.76
Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass. J Card Fail (2016) 0.76
Serum positive for the autoantibody against the β(1)-adrenoceptor from Chinese patients with congestive heart failure decreases I(ss) in mouse cardiac myocytes. Clin Dev Immunol (2011) 0.75
Measurement of antibody effects on cellular function of isolated cardiomyocytes. J Vis Exp (2013) 0.75
MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression. Sci Rep (2017) 0.75
Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors. J Am Coll Cardiol (2017) 0.75
Proliferation in cardiac fibroblasts induced by β1-adrenoceptor autoantibody and the underlying mechanisms. Sci Rep (2016) 0.75
Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload. PLoS One (2013) 0.75
Pathophysiological role of autoantibodies against G-protein-coupled receptors in the cardiovascular system. Exp Clin Cardiol (2005) 0.75
A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit. J Interv Card Electrophysiol (2015) 0.75
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J (1975) 2.71
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med (2000) 2.62
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem Biophys Res Commun (1976) 2.29
Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation (1989) 2.24
Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation (1997) 2.16
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med (2001) 2.07
A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J (2000) 1.96
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J (1980) 1.85
Beta-blockers and sudden cardiac death. Ann Intern Med (1995) 1.83
Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol (2001) 1.80
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol (1991) 1.66
Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc (1973) 1.66
Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation (1997) 1.64
The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish population. JAMA (1994) 1.64
Immunoperoxidase visualisation of microtubules and microtubular proteins. Nature (1976) 1.56
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol (2001) 1.55
Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J (1992) 1.55
Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet (1979) 1.55
Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res (1993) 1.53
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology (1998) 1.51
Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting. Eur Heart J (1996) 1.51
Early changes in longitudinal performance predict future improvement in global left ventricular function during long term beta adrenergic blockade. Heart (2000) 1.49
Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol. Eur Heart J (1999) 1.48
Prognosis of acute myocardial infarction in diabetic and non-diabetic patients. Diabet Med (1993) 1.47
Eligibility for intravenous thrombolysis in suspected acute myocardial infarction. Circulation (1990) 1.46
Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ (1993) 1.44
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci (2000) 1.42
Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. Int J Cardiol (1999) 1.40
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med (2003) 1.39
Hypertonic saline without or with dextran-70 in the treatment of experimental acute myocardial ischemia and reperfusion. Crit Care Med (1999) 1.37
Evidence for reversible microclustering of lentil lectin membrane receptors on HeLa cells. FEBS Lett (1980) 1.34
Immunomodulatory properties of cystatins. Cell Mol Life Sci (2002) 1.34
The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation (1985) 1.34
Distress correlates with the degree of chest pain: a description of patients awaiting revascularisation. Heart (1996) 1.30
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors. FEBS Lett (1984) 1.25
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med (1995) 1.23
Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation (2000) 1.22
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol. Br Heart J (1974) 1.20
Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol (2000) 1.18
Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension (1997) 1.18
In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci (2006) 1.15
Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation (1996) 1.14
Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation (2001) 1.14
Effect of acupuncture in patients with angina pectoris. Eur Heart J (1991) 1.14
Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol (1991) 1.12
Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila. J Clin Microbiol (1983) 1.12
Patients admitted to the emergency room with symptoms indicative of acute myocardial infarction. J Intern Med (1991) 1.12
Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes (1999) 1.11
Are patients truthful about their smoking habits? A validation of self-report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease. J Intern Med (2001) 1.11
beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody. Proc Natl Acad Sci U S A (1985) 1.11
Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res (2001) 1.10
Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci U S A (1997) 1.10
Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J (1980) 1.10
Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg (1999) 1.10
The production and characterization of antibodies against beta-adrenergic antagonists. Biochem Pharmacol (1978) 1.09
Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J Immunol (1996) 1.08
Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol (1989) 1.07
Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents. Br Heart J (1979) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands. Biol Cell (1987) 1.06
Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation (1989) 1.05
In vitro work load and rat heart metabolism. I. Effect on protein synthesis. Acta Physiol Scand (1972) 1.05
Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J Biol Chem (1996) 1.05
Epitopic analysis of the Toxoplasma gondii major surface antigen SAG1. Mol Biochem Parasitol (1994) 1.04
Complications prior to revascularization among patients waiting for coronary artery bypass grafting and percutaneous transluminal coronary angioplasty. Eur Heart J (1996) 1.04
The role of beta-blockers in left ventricular dysfunction and heart failure. Drugs (1997) 1.04
Quality of life five years after myocardial infarction. Eur Heart J (1989) 1.04
Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab (2006) 1.04
Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J (1993) 1.04
Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol (2000) 1.04
Effects of levamisole on spontaneous rosette-forming cells in murine spleen. Eur J Immunol (1976) 1.01